---
title: "Liquidity Event, Definition | MedTech Terms"
description: "Any transaction that converts illiquid private-company equity into cash or freely tradable securities, typically IPO, M&amp;A, or secondary tender."
lang: en
json-ld: |
  {
    "@context": "https://schema.org",
    "@graph": [
      {
        "@type": "DefinedTerm",
        "@id": "https://medtechterms.com/terms/liquidity-event#term",
        "name": "Liquidity Event",
        "description": "A liquidity event is any transaction that converts illiquid private-company equity into cash or freely tradable public securities. The three primary forms in MedTech are: an IPO, an acquisition (M&A), or a secondary tender offer in which existing investors (or specialized secondary funds) buy shares from earlier holders. The term often appears in vesting acceleration provisions, board approval covenants, and 409A valuation refresh triggers.",
        "url": "https://medtechterms.com/terms/liquidity-event",
        "termCode": "liquidity-event",
        "inDefinedTermSet": {
          "@type": "DefinedTermSet",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com/terms"
        }
      },
      {
        "@type": "Article",
        "@id": "https://medtechterms.com/terms/liquidity-event#article",
        "headline": "Liquidity Event",
        "description": "Any transaction that converts illiquid private-company equity into cash or freely tradable securities, typically IPO, M&A, or secondary tender.",
        "url": "https://medtechterms.com/terms/liquidity-event",
        "mainEntityOfPage": {
          "@type": "WebPage",
          "@id": "https://medtechterms.com/terms/liquidity-event"
        },
        "about": {
          "@id": "https://medtechterms.com/terms/liquidity-event#term"
        },
        "articleSection": "Investment & Finance",
        "inLanguage": "en",
        "keywords": "Liquidity Event, Investment & Finance, medical device, MedTech",
        "author": {
          "@type": "Person",
          "name": "Christian Espinosa",
          "jobTitle": "Founder, Blue Goat Cyber",
          "url": "https://bluegoatcyber.com"
        },
        "publisher": {
          "@type": "Organization",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "isPartOf": {
          "@type": "WebSite",
          "name": "MedTech Terms",
          "url": "https://medtechterms.com"
        },
        "datePublished": "2026-05-09",
        "dateModified": "2026-05-09",
        "citation": [
          {
            "@type": "CreativeWork",
            "name": "NVCA Model Legal Documents",
            "url": "https://nvca.org/model-legal-documents/",
            "publisher": {
              "@type": "Organization",
              "name": "NVCA"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "IRS, Topic 427 Stock Options",
            "url": "https://www.irs.gov/taxtopics/tc427",
            "publisher": {
              "@type": "Organization",
              "name": "IRS"
            }
          },
          {
            "@type": "CreativeWork",
            "name": "Silicon Valley Bank - Healthcare Reports",
            "url": "https://www.svb.com/trends-insights/",
            "publisher": {
              "@type": "Organization",
              "name": "SVB"
            }
          }
        ],
        "mentions": [
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/ipo#term",
            "name": "Initial Public Offering",
            "alternateName": "IPO",
            "url": "https://medtechterms.com/terms/ipo"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/m-and-a#term",
            "name": "Mergers and Acquisitions",
            "alternateName": "M&A",
            "url": "https://medtechterms.com/terms/m-and-a"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/exit-multiple#term",
            "name": "Exit Multiple",
            "url": "https://medtechterms.com/terms/exit-multiple"
          },
          {
            "@type": "DefinedTerm",
            "@id": "https://medtechterms.com/terms/vesting#term",
            "name": "Vesting Schedule",
            "url": "https://medtechterms.com/terms/vesting"
          }
        ]
      },
      {
        "@type": "BreadcrumbList",
        "itemListElement": [
          {
            "@type": "ListItem",
            "position": 1,
            "name": "Home",
            "item": "https://medtechterms.com/"
          },
          {
            "@type": "ListItem",
            "position": 2,
            "name": "Terms",
            "item": "https://medtechterms.com/terms"
          },
          {
            "@type": "ListItem",
            "position": 3,
            "name": "Investment & Finance",
            "item": "https://medtechterms.com/terms?cat=Investment%20%26%20Finance"
          },
          {
            "@type": "ListItem",
            "position": 4,
            "name": "Liquidity Event",
            "item": "https://medtechterms.com/terms/liquidity-event"
          }
        ]
      }
    ]
  }
---

[

MedTech Terms

The authoritative reference



](/)

Browse

Learn

[Latest](/latest)

About

1.  [Home](/)
2.  /
3.  [Terms](/terms)
4.  /
5.  [Investment & Finance](/terms?cat=Investment%20%26%20Finance)
6.  /
7.  Liquidity Event

[All terms](/terms)

Investment & Finance [Startup Lifecycle](/ecosystems/startup-lifecycle)

# Liquidity Event

Any transaction that converts illiquid private-company equity into cash or freely tradable securities, typically IPO, M&A, or secondary tender.

Reviewed by [Christian Espinosa, Founder, Blue Goat Cyber](/authors/christian-espinosa) Last reviewed May 9, 2026 

## Definition

A liquidity event is any transaction that converts illiquid private-company equity into cash or freely tradable public securities. The three primary forms in MedTech are: an  [IPO](/terms/ipo), an acquisition ( [M&A](/terms/m-and-a)), or a secondary tender offer in which existing investors (or specialized secondary funds) buy shares from earlier holders. The term often appears in vesting acceleration provisions, board approval covenants, and  [409A valuation](/terms/409a-valuation) refresh triggers. 

## What this means in practice

MedTech median time to liquidity is significantly longer than software (commonly 8-12 years from founding) due to clinical-trial and regulatory timelines. Secondary transactions have become more common as a partial-liquidity option for long-tenured founders and employees. 

Common pitfalls

-   • Assuming a secondary tender qualifies as the 'liquidity event' under double-trigger acceleration clauses, usually it does not. 

## Related terms

Grouped by theme 

### Editor's picks

· Hand-selected related concepts 

[

Investment & Finance

Exit Multiple

Valuation ratio applied at exit, e.g., enterprise value to revenue.





](/terms/exit-multiple)[

Investment & Finance

Initial Public Offering(IPO) 

First sale of a company's stock to public investors via a registered SEC offering, typically on NYSE or Nasdaq.





](/terms/ipo)[

Investment & Finance

Mergers and Acquisitions(M&A) 

Transactions in which one company acquires or combines with another, the dominant MedTech exit path, typically a strategic acquisition by an established player.





](/terms/m-and-a)[

Investment & Finance

Vesting Schedule

Timeline over which equity is earned by an employee or founder.





](/terms/vesting)

### More in Investment & Finance

· Same category 

[

Investment & Finance

409A Valuation

An independent fair-market-value appraisal of common stock used to set tax-compliant strike prices for employee stock options.





](/terms/409a-valuation)[

Investment & Finance

Anti-Dilution Protection

Adjustment that protects investors if the company raises a future round at a lower price.





](/terms/anti-dilution)[

Investment & Finance

Bridge Round

Interim financing between priced rounds, usually convertible.





](/terms/bridge-round)[

Investment & Finance

Burn Rate

Rate at which a company spends cash, typically expressed monthly.





](/terms/burn-rate)

Cited by

Where this term appears across MedTech Terms.

Ecosystems (1)

-   [Startup Lifecycle](/ecosystems/startup-lifecycle)

## Primary references

3 sources 

Link health:  3 verified · last checked 2026-06-20 

NVCA· 1 IRS· 1 SVB· 1 

1.  [1 
    
    NVCA Model Legal Documents
    
    Verified 
    
    NVCA · nvca.org 
    
    
    
    ](https://nvca.org/model-legal-documents/)
2.  [2 
    
    IRS, Topic 427 Stock Options
    
    Verified 
    
    IRS · irs.gov 
    
    
    
    ](https://www.irs.gov/taxtopics/tc427)
3.  [3 
    
    Silicon Valley Bank - Healthcare Reports
    
    Verified 
    
    SVB · svb.com 
    
    
    
    ](https://www.svb.com/trends-insights/)

Inline markers like \[1\]  jump to the matching reference above.

Sponsor note

### Diligencing a MedTech cybersecurity posture?

Blue Goat Cyber supports investors and acquirers with cybersecurity diligence on connected MedTech assets.

[Book a 30-minute discovery session](https://go.bluegoatcyber.com/meetings/blue-goat-cyber/discovery-session)

-   No obligation
-   Expert-led from minute one
-   NDA available on request

MedTech Terms is a community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com). Definitions are independent of any vendor.

On this term

Category

Investment & Finance

Sources

3

Updated

5/9/2026

[Compare with another term](/compare?a=liquidity-event)

Learn in 60 seconds

Card Lesson Quiz

Any transaction that converts illiquid private-company equity into cash or freely tradable securities, typically IPO, M&A, or secondary tender.

-   · MedTech median time to liquidity is significantly longer than software (commonly 8-12 years from founding) due to clinical-trial and regulatory timelines. 
-   · Secondary transactions have become more common as a partial-liquidity option for long-tenured founders and employees. 
-   · The three primary forms in MedTech are: an IPO, an acquisition (M&A), or a secondary tender offer in which existing investors (or specialized secondary funds) buy shares from earlier holders. 

Remember this

Watch out: Assuming a secondary tender qualifies as the 'liquidity event' under double-trigger acceleration clauses, usually it does not.

Related terms

-   [Initial Public Offering(IPO) ](/terms/ipo)
-   [Mergers and Acquisitions(M&A) ](/terms/m-and-a)
-   [Exit Multiple ](/terms/exit-multiple)
-   [Vesting Schedule ](/terms/vesting)

You may also need

Auto-suggested from Investment & Finance and shared keywords.

-   [Drag-Along and Tag-Along Rights ](/terms/drag-tag-along)
-   [Earn-Out ](/terms/earn-out)
-   [Simple Agreement for Future Equity(SAFE) ](/terms/safe-note)
-   [Preferred Stock ](/terms/preferred-stock)
-   [Royalty Financing ](/terms/royalty-financing)
-   [Series A / B / C Financing Rounds ](/terms/series-funding)

[All Investment & Finance terms](/terms?cat=Investment%20%26%20Finance)

MedTech Terms 

An authoritative, plain-language reference for the regulatory, quality, cybersecurity, and software terms that shape modern medical devices.

Browse

-   [All terms](/terms)
-   [A–Z index](/a-z)
-   [Categories](/categories)
-   [Ecosystems](/ecosystems)
-   [Learning paths](/paths)
-   [Compare terms](/compare)
-   [Quiz](/quiz)

Resources

-   [FDA Medical Devices](https://www.fda.gov/medical-devices)
-   [EU MDR](https://eur-lex.europa.eu/eli/reg/2017/745/oj)
-   [IMDRF](https://www.imdrf.org/)
-   [Methodology](/methodology)
-   [Changelog](/changelog)
-   [Editor: Christian Espinosa](/authors/christian-espinosa)
-   [About this site](/about)

© 2026 MedTech Terms. Reference content for educational purposes - not regulatory advice. A community resource sponsored by [Blue Goat Cyber](https://bluegoatcyber.com)